Community-Acquired Clostridium Difficile Infection: Awareness and Clinical Implications

Journal for Nurse Practitioners

Volumn 9, Issue 1, 2013, Pages 1-6

  Juneau, Cheryl ^a   Mendias, Elnora Nonie P ^a   Wagal, Nihas ^c   Loeffelholz, Michael ^b   Savidge, Tor ^a   Croisant, Sharon ^b   Dann, Sara M ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NONE

Author keywords

Clostridium difficile infection; Community acquired Clostridium difficile; North American pulsed field type 1; PCR ribotype 027

Indexed keywords

EID: 84872147783     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2012.10.007     Document Type: Article

References (43)

1. Laino C, Chang L Digestive disorders health center, C. diff on the rise outside the hospital. WebMD Accessed May 17, 2012. http://www.webmd.com/digestive-disorders/news/20110920/c-diff-on-the-rise-outside%20the%20hospital.
2. Centers for Disease Control and Prevention Frequently asked questions about Clostridium difficile for healthcare providers Updated March 6, 2012. Accessed May 25, 2012. http://www.cdc.gov/HAI/organisms/cdiff-faqs-HCP.html.
3. Centers for Disease Control and Prevention Severe Clostridium difficile-associated disease in population previously at low risk-four states Accessed August 27, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5447a1.htm.
4. McFarland LV, Clarridge JE, Beneda HW, Raugi GJ Fluoroquinoline use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis 2007, 45(9):1141-1151.
5. Kasper AM, Nyazee HA, Yokoe DS, et al. A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol 2012, 33(5):470-476.
6. Shin BM, Moon SJ, Kim YS, Shin WC, Yoo HM Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital. J Clin Microbiol 2011, 49(6):2161-2165.
7. Rakel R Infectious diarrhea. Textbook of Family Medicine 2007, 329-331. WB Saunders, Philadelphia, PA. R. Rakel (Ed.).
8. Rakel R Infectious diarrhea. Saunders Manual of Medical Practice 1996, 858-861. WB Saunders, Philadelphia, PA. 7th ed. R. Rakel (Ed.).
9. Aberra FN, Gronczewski CA, Katz JP Clostridium Difficile Colitis. Medscape Reference: Drugs, Diseases and Procedures Updated May 18, 2012. Accessed April 22, 2012. http://emedicine.medscape.com/article/186458-overview.
10. Clostridium Difficile Colitis (antibiotic-associated colitis, C. difficile colitis, C. diff, C diff). Updated June 2, 2008. Accessed April 19, 2012. http://www.medicinenet.com/script/main/art.asp?articlekey=317&pf=3&page=2.
11. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Disease Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31(5):431-455.
12. McFarland LV, Mulligan ME, Kwok RY, Stamm WE Nosocomial acquisition of Clostridium difficile infection. N Eng J Med 1989, 320(4):204-210.
13. Kuijper EJ, Coignard B, Tull P, ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl. 6):2-18.
14. Rupnik M, Wilcox MH, Gerding DN Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7(7):526-536.
15. Centers for Disease Control and Prevention Vital Signs: preventing Clostridium difficile infections Accessed May 25, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6109a3htm?s_cid=mm6109a3_w.
16. Khanna SK, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012, 107:89-95.
17. Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM Incidence and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 2011, 11:194.
18. Kyne L, Hammel MB, Polavaram R, Kelly CP Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34(3):346-353.
19. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007, 28:1219-1227.
20. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW Economic healthcare costs of Clostridium difficile infections: a systematic review. J Hosp Infect 2010, 74:309-318.
21. Eastwood K, Else P, Charlett A, Wilcox M Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009, 47(10):3211-3217.
22. Pancholi P, Kelly C, Raczkowski M, Balada-Llasat JM Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. J Clin Microbiol 2012, 50(4):1331-1335.
23. Kvach EJ, Ferguson D, Riska PF, Landry ML Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010, 48(1):109-114.
24. Chapin KC, Dickenson RA, Wu F, Andrea SB Comparison of five assays for detection of Clostridium difficile toxin. J Mol Diagn 2011, 13(4):395-400.
25. Vasoo S, Stevens J, Portillo L, et al. Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme dehydrogenase/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection. J Microbiol Immunol Infect 2012, In press.
26. Crobach MJT, Dekkers OM, Wilcox MH, Kuijper EJ European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009, 15(12):1053-1066.
27. Planche T, Aghaizu A, Holliman R, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008, 8(12):777-784.
28. Carroll KC, Loeffelholz M Conventional versus molecular methods for the detection of Clostridium difficile. J Clin Microbiol 2011, 49(Suppl 9):49s-52s.
29. Carroll KC Tests for the diagnosis of Clostridium difficile infections. The next generation. Anaerobe 2011, 17(4):170-174.
30. Aichinger E, Schleck CD, Harmsen WS, Nyre LM, Patel R Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbial 2008, 46(11):3795-3797.
31. Peterson LR, Robiscek A Does my patient have Clostridium difficile infection?. Ann Intern Med 2009, 151(3):176-179.
32. Kapoor K, Chandra M, Nag D, Paliwal JK, Gupta RC, Saxena RC Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res 1999, 19(3):83-88.
33. Musher DM, Logan N, Hamill RJ, et al. Nitazoxianide for the treatment of Clostridium difficile colitis. Clin Infect Dis 2006, 43:421-427.
34. Aas J, Gessert CE, Bakken JS Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003, 36(5):580-585.
35. Giannasca PJ, Warny M Active and passive immunization against Clostridium difficile diarrhea and colitis. Vaccine 2004, 22(7):848-856.
36. Wilcox MH Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhea. J Antimicrob Chemother 2004, 53(5):882-884.
37. Salcedo J, Keates S, Pothoulakis C, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997, 41(3):366-370.
38. Koo HL, Koo CD, Musher DM, DuPont HL Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis 2009, 48:598-605.
39. US National Library of Health. Accessed October 15, 2012. http://www.clinicaltrials.gov/.
40. Johnson AP, Wilcox MH Fidaxomicin: a new option for the treatment of Clostridium difficile infection. J Antimicrob Chemother 2012, [Epub ahead of print].
41. Aroniadis OC, Brandt LJ Fecal microbiota transplantation: past, present, and future. Curr Opin Gastroenterol 2012 Oct 4, [Epub ahead of print].
42. Dubberke E, Gerding D Rationale for hand hygiene recommendations after caring for a patient with Clostridium difficile infection. The Society for Healthcare Epidemiology of America Fall 2011 Update Accessed May 25, 2012. http://www.shea-online.org/Portals/0/CDI%20hand%20hygiene%20Update.pdf.
43. Pepin J, Alary ME, Vlaiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005, 40:1591-1597.